Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV- and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy.
Clin Cancer Res
; 25(21): 6463-6474, 2019 11 01.
Article
in En
| MEDLINE
| ID: mdl-31266830
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrroles
/
Morpholines
/
Inhibitor of Apoptosis Proteins
/
X-Linked Inhibitor of Apoptosis Protein
/
Squamous Cell Carcinoma of Head and Neck
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Country of publication:
United States